Cargando…

Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure

AIM: Immune checkpoint inhibitor (ICI) efficacy is undefined for melanoma brain metastases (MBM) with concurrent corticosteroid exposure. MATERIALS & METHODS: We retrospectively evaluated patients with untreated MBM who received corticosteroids (≥1.5 mg dexamethasone equivalent) within 30 days o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tringale, Kathryn R, Reiner, Anne S, Sehgal, Ryka R, Panageas, Katherine, Betof Warner, Allison S, Postow, Michael A, Moss, Nelson S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996406/ https://www.ncbi.nlm.nih.gov/pubmed/36802833 http://dx.doi.org/10.2217/cns-2022-0014

Ejemplares similares

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
por: Loo, Kimberly, et al.
Publicado: (2022)

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
por: Rosner, Samuel, et al.
Publicado: (2018)

Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids
por: Tokunaga, Akihiro, et al.
Publicado: (2019)

17. MELANOMA BRAIN METASTASIS: PRESENTATION, TREATMENT AND OUTCOMES IN THE AGE OF TARGETED- AND IMMUNO-THERAPIES
por: Bander, Evan D, et al.
Publicado: (2020)

Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
por: Atkinson, Thomas M, et al.
Publicado: (2023)

Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
por: Liermann, Jakob, et al.
Publicado: (2020)

The future of cancer immunotherapy: microenvironment-targeting combinations
por: Murciano-Goroff, Yonina R., et al.
Publicado: (2020)

Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment
por: Loo, Kimberly, et al.
Publicado: (2022)

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
por: Anderson, Erik S., et al.
Publicado: (2017)

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
por: Betof Warner, Allison, et al.
Publicado: (2023)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
por: Wilcox, Jessica, et al.
Publicado: (2021)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy
por: Peng, Xiyu, et al.
Publicado: (2023)

Uncovering the hidden structure of dynamic T cell composition in peripheral blood during cancer immunotherapy: a topic modeling approach
por: Peng, Xiyu, et al.
Publicado: (2023)

Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases
por: Bander, Evan D., et al.
Publicado: (2023)

Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review
por: Weaver, Bradley D, et al.
Publicado: (2019)

Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
por: Page, David B, et al.
Publicado: (2014)

Extensive necrosis of visceral melanoma metastases after immunotherapy
por: Stoeter, David, et al.
Publicado: (2008)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus
por: Costa, Bruno Almeida, et al.
Publicado: (2022)

57. CIRCULATING TUMOR CELLS (CTC) IN CEREBROSPINAL FLUID (CSF) AS A PREDICTOR OF SURVIVAL IN CNS METASTASES
por: Diaz, Maria, et al.
Publicado: (2020)

Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases
por: Fernandes, Gil Nuno Castro
Publicado: (2023)

Kaposi Sarcoma in the United States: Understanding Disparate Risk
por: Reiner, Anne S, et al.
Publicado: (2022)

Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023)

Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023)

Melanoma with gastric metastases
por: Wong, Katherine, et al.
Publicado: (2016)

LMD-02. Cerebrospinal Fluid Diversion for Metastatic Leptomeningeal Carcinomatosis: Palliative, Procedural and Oncologic Outcomes
por: Bander, Evan D, et al.
Publicado: (2021)

SDPS-46 CENTRAL NERVOUS SYSTEM (CNS)-RELATED MORTALITY IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER
por: Ferraro, Emanuela, et al.
Publicado: (2023)

Complete Response After Stereotactic Body Radiation Therapy With Concurrent Immunotherapy for Vaginal Melanoma
por: Schonewolf, Caitlin A., et al.
Publicado: (2021)

MMAP-06 INTEGRATED TEAM-BASED BRAIN METASTASIS CARE REDUCES PATIENT VISITS AND SHORTENS TIME TO ADJUVANT IRRADIATION
por: Moss, Nelson S, et al.
Publicado: (2022)

PAIN RELIEF: Tapes 1 - 5
por: Moore, Ryka
Publicado: (2002)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
por: Moyers, Justin T., et al.
Publicado: (2021)

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
por: Momtaz, Parisa, et al.
Publicado: (2017)

Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment()
por: Cassidy, Michael R., et al.
Publicado: (2017)

Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy
por: Genova, Pietro, et al.
Publicado: (2017)

THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019)

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
por: Yusuf, Mehran, et al.
Publicado: (2021)

Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6eejlig9eurvaudoput5tb6hbv